274.06  0.65 (0.24%)		12-12 16:00
Open: 273.81 High: 275.875 Volume: 3,473,073		Pre. Close: 273.41 Low: 272.15 Market Cap: 147,316(M)

Short term
Mid term
Targets	6-month :	351.96	1-year :	383.39
Resists	First :	301.33	Second :	328.25
Pivot price	280.25
Supports	First :	257.79	Second :	214.48
MAs	MA(5) :	274.68	MA(20) :	281.49
	MA(100) :	315.85	MA(250) :	303.73
MACD	MACD :	-9	Signal :	-9.4
%K %D	K(14,3) :	42	D(3) :	43.7
RSI	RSI(14): 33.7
52-week	High :	346.85	Low :	257.79

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ AMGN ] has closed above bottom band by 27.5%. Bollinger Bands are 14.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	276.27 - 277.82	277.82 - 279.23
Low:	268.01 - 270.06	270.06 - 271.94
Close:	271.11 - 274.06	274.06 - 276.76

"A"m"g"e"n" "I"n"c"." "d"i"s"c"o"v"e"r"s"," "d"e"v"e"l"o"p"s"," "m"a"n"u"f"a"c"t"u"r"e"s"," "a"n"d" "d"e"l"i"v"e"r"s" "h"u"m"a"n" "t"h"e"r"a"p"e"u"t"i"c"s" "w"o"r"l"d"w"i"d"e"." "I"t" "f"o"c"u"s"e"s" "o"n" "i"n"f"l"a"m"m"a"t"i"o"n"," "o"n"c"o"l"o"g"y"/"h"e"m"a"t"o"l"o"g"y"," "b"o"n"e" "h"e"a"l"t"h"," "c"a"r"d"i"o"v"a"s"c"u"l"a"r" "d"i"s"e"a"s"e"," "n"e"p"h"r"o"l"o"g"y"," "a"n"d" "n"e"u"r"o"s"c"i"e"n"c"e" "a"r"e"a"s"." "T"h"e" "c"o"m"p"a"n"y"'"s" "p"r"o"d"u"c"t"s" "i"n"c"l"u"d"e" "E"n"b"r"e"l" "t"o" "t"r"e"a"t" "p"l"a"q"u"e" "p"s"o"r"i"a"s"i"s"," "r"h"e"u"m"a"t"o"i"d" "a"r"t"h"r"i"t"i"s"," "a"n"d" "p"s"o"r"i"a"t"i"c" "a"r"t"h"r"i"t"i"s";" "N"e"u"l"a"s"t"a" "t"h"a"t" "r"e"d"u"c"e"s" "t"h"e" "c"h"a"n"c"e" "o"f" "i"n"f"e"c"t"i"o"n" "d"u"e" "a" "l"o"w" "w"h"i"t"e" "b"l"o"o"d" "c"e"l"l" "c"o"u"n"t" "i"n" "p"a"t"i"e"n"t"s" "c"a"n"c"e"r";" "P"r"o"l"i"a" "t"o" "t"r"e"a"t" "p"o"s"t"m"e"n"o"p"a"u"s"a"l" "w"o"m"e"n" "w"i"t"h" "o"s"t"e"o"p"o"r"o"s"i"s";" "X"g"e"v"a" "f"o"r" "s"k"e"l"e"t"a"l"-"r"e"l"a"t"e"d" "e"v"e"n"t"s" "p"r"e"v"e"n"t"i"o"n";" "O"t"e"z"l"a" "f"o"r" "t"h"e" "t"r"e"a"t"m"e"n"t" "o"f" "a"d"u"l"t" "p"a"t"i"e"n"t"s" "w"i"t"h" "p"l"a"q"u"e" "p"s"o"r"i"a"s"i"s"," "p"s"o"r"i"a"t"i"c" "a"r"t"h"r"i"t"i"s"," "a"n"d" "o"r"a"l" "u"l"c"e"r"s" "a"s"s"o"c"i"a"t"e"d" "w"i"t"h" "B"e"h"ç"e"t"'"s" "d"i"s"e"a"s"e";" "A"r"a"n"e"s"p" "t"o" "t"r"e"a"t" "a" "l"o"w"e"r"-"t"h"a"n"-"n"o"r"m"a"l" "n"u"m"b"e"r" "o"f" "r"e"d" "b"l"o"o"d" "c"e"l"l"s" "a"n"d" "a"n"e"m"i"a";" "K"Y"P"R"O"L"I"S" "t"o" "t"r"e"a"t" "p"a"t"i"e"n"t"s" "w"i"t"h" "r"e"l"a"p"s"e"d" "o"r" "r"e"f"r"a"c"t"o"r"y" "m"u"l"t"i"p"l"e" "m"y"e"l"o"m"a";" "a"n"d" "R"e"p"a"t"h"a"," "w"h"i"c"h" "r"e"d"u"c"e"s" "t"h"e" "r"i"s"k"s" "o"f" "m"y"o"c"a"r"d"i"a"l" "i"n"f"a"r"c"t"i"o"n"," "s"t"r"o"k"e"," "a"n"d" "c"o"r"o"n"a"r"y" "r"e"v"a"s"c"u"l"a"r"i"z"a"t"i"o"n"." "I"t" "a"l"s"o" "m"a"r"k"e"t"s" "N"p"l"a"t"e"," "V"e"c"t"i"b"i"x"," "M"V"A"S"I"," "P"a"r"s"a"b"i"v"," "E"P"O"G"E"N"," "K"A"N"J"I"N"T"I"," "B"L"I"N"C"Y"T"O"," "A"i"m"o"v"i"g"," "E"V"E"N"I"T"Y"," "A"M"G"E"V"I"T"A"T"M"," "S"e"n"s"i"p"a"r"/"M"i"m"p"a"r"a"," "N"E"U"P"O"G"E"N"," "I"M"L"Y"G"I"C"," "C"o"r"l"a"n"o"r"," "a"n"d" "A"V"S"O"L"A"." "A"m"g"e"n" "I"n"c"." "s"e"r"v"e"s" "h"e"a"l"t"h"c"a"r"e" "p"r"o"v"i"d"e"r"s"," "i"n"c"l"u"d"i"n"g" "p"h"y"s"i"c"i"a"n"s" "o"r" "t"h"e"i"r" "c"l"i"n"i"c"s"," "d"i"a"l"y"s"i"s" "c"e"n"t"e"r"s"," "h"o"s"p"i"t"a"l"s"," "a"n"d" "p"h"a"r"m"a"c"i"e"s"." "I"t" "d"i"s"t"r"i"b"u"t"e"s" "i"t"s" "p"r"o"d"u"c"t"s" "t"h"r"o"u"g"h" "p"h"a"r"m"a"c"e"u"t"i"c"a"l" "w"h"o"l"e"s"a"l"e" "d"i"s"t"r"i"b"u"t"o"r"s"," "a"s" "w"e"l"l" "a"s" "d"i"r"e"c"t"-"t"o"-"c"o"n"s"u"m"e"r" "c"h"a"n"n"e"l"s"." "I"t" "h"a"s" "c"o"l"l"a"b"o"r"a"t"i"o"n" "a"g"r"e"e"m"e"n"t"s" "w"i"t"h" "N"o"v"a"r"t"i"s" "P"h"a"r"m"a" "A"G";" "U"C"B";" "B"a"y"e"r" "H"e"a"l"t"h"C"a"r"e" "L"L"C";" "B"e"i"G"e"n"e"," "L"t"d".";" "E"l"i" "L"i"l"l"y" "a"n"d" "C"o"m"p"a"n"y";" "D"a"t"o"s" "H"e"a"l"t"h";" "a"n"d" "V"e"r"a"s"t"e"m"," "I"n"c"." "t"o" "e"v"a"l"u"a"t"e" "V"S"-"6"7"6"6" "i"n" "c"o"m"b"i"n"a"t"i"o"n" "w"i"t"h" "l"u"m"a"k"r"a"s"t"m" "("S"o"t"o"r"a"s"i"b")" "i"n" "p"a"t"i"e"n"t"s" "w"i"t"h" "K"R"A"S" "G"1"2"C"-"m"u"t"a"n"t" "n"o"n"-"s"m"a"l"l" "c"e"l"l" "l"u"n"g" "c"a"n"c"e"r"." "I"t" "h"a"s" "a"n" "a"g"r"e"e"m"e"n"t" "w"i"t"h" "K"y"o"w"a" "K"i"r"i"n" "C"o"."," "L"t"d"." "t"o" "j"o"i"n"t"l"y" "d"e"v"e"l"o"p" "a"n"d" "c"o"m"m"e"r"c"i"a"l"i"z"e" "K"H"K"4"0"8"3"," "a" "P"h"a"s"e" "3"-"r"e"a"d"y" "a"n"t"i"-"O"X"4"0" "f"u"l"l"y" "h"u"m"a"n" "m"o"n"o"c"l"o"n"a"l" "a"n"t"i"b"o"d"y" "f"o"r" "t"h"e" "t"r"e"a"t"m"e"n"t" "o"f" "a"t"o"p"i"c" "d"e"r"m"a"t"i"t"i"s" "a"n"d" "o"t"h"e"r" "a"u"t"o"i"m"m"u"n"e" "d"i"s"e"a"s"e"s";" "a"n"d" "r"e"s"e"a"r"c"h" "a"n"d" "d"e"v"e"l"o"p"m"e"n"t" "c"o"l"l"a"b"o"r"a"t"i"o"n" "w"i"t"h" "N"e"u"m"o"r"a" "T"h"e"r"a"p"e"u"t"i"c"s"," "I"n"c"." "a"n"d" "P"l"e"x"i"u"m"," "I"n"c"." "A"m"g"e"n" "I"n"c"." "w"a"s" "i"n"c"o"r"p"o"r"a"t"e"d" "i"n" "1"9"8"0" "a"n"d" "i"s" "h"e"a"d"q"u"a"r"t"e"r"e"d" "i"n" "T"h"o"u"s"a"n"d" "O"a"k"s"," "C"a"l"i"f"o"r"n"i"a".

Thu, 12 Dec 2024
AMGN: 3 Biotech Stocks With Promising Pipelines - StockNews.com

Thu, 12 Dec 2024
Wilmington Savings Fund Society FSB Purchases 5,748 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Thu, 12 Dec 2024
Why Amgen (AMGN) is a Top Growth Stock for the Long-Term - Yahoo Finance

Thu, 12 Dec 2024
Tudor Financial Inc. Purchases New Shares in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Thu, 12 Dec 2024
2,500 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by Morse Asset Management Inc - MarketBeat

Thu, 12 Dec 2024
Why Amgen Inc. (AMGN) Is the Best Safe Stock to Buy According to Analysts? - Insider Monkey

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Shares Out	538 (M)
Shares Float	536 (M)
Held by Insiders	0.2 (%)
Held by Institutions	81.1 (%)
Shares Short	9,810 (K)
Shares Short P.Month	9,370 (K)

EPS	7.82
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	14
Profit Margin	13 %
Operating Margin	24.1 %
Return on Assets (ttm)	4.5 %
Return on Equity (ttm)	55.7 %
Qtrly Rev. Growth	23.2 %
Gross Profit (p.s.)	0
Sales Per Share	60.51
EBITDA (p.s.)	22.78
Qtrly Earnings Growth	62 %
Operating Cash Flow	7,260 (M)
Levered Free Cash Flow	4,570 (M)

PE Ratio	35.04
PEG Ratio	0
Price to Book value	19.57
Price to Sales	4.52
Price to Cash Flow	20.29

Dividend	2.25
Forward Dividend	0
Dividend Yield	0.8%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.